Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus

Krishnavathana Hassan, Rubina A. Heptulla

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: The purpose of this study was to determine the effect of adjuvant premeal pramlintide with postmeal insulin on postprandial hyperglycemia in children with type 1 diabetes mellitus (T1DM). Methods: Eight adolescents with T1DM on intensive insulin therapy participated in an open-label, non-randomized, crossover study, comparing postprandial glucose excursions in study A (prescribed insulin regimen and given premeal) vs. study B (pramlintide + insulin). Prandial insulin dose for study B was decreased by 20% and given postmeal, while pramlintide was given just before the meal. Blood glucose (BG), glucagon, and pramlintide concentrations were measured basally and at timed intervals during a 300-min study period. Results: Postprandial incremental BG for the duration of the study was reduced in study B vs. study A with AUC(-60to300min) (area under the curve) at 6600 ± 2371 vs. 20230 ± 3126 mg/dL/min (367 ± 132 vs. 1124 ± 174 mmol/L/min) (p < 0.001). Glucagon concentration was suppressed for ∼120 min following administration of 30 μg of pramlintide and postmeal insulin (p < 0.003). No severe hypoglycemic episodes were experienced in this study. Conclusions: Postprandial hyperglycemia is considerably reduced in adolescents with T1DM when treated with fixed-dose premeal pramlintide, and precisely calculated postmeal insulin, without significant side effects.

Original languageEnglish (US)
Pages (from-to)264-268
Number of pages5
JournalPediatric Diabetes
Volume10
Issue number4
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Hyperglycemia
Insulin
Glucagon
Area Under Curve
Meals
Blood Glucose
Hypoglycemic Agents
Cross-Over Studies
pramlintide
Glucose

Keywords

  • Children
  • Glucagon
  • Postprandial hyperglycemia
  • Pramlintide
  • T1DM

ASJC Scopus subject areas

  • Internal Medicine
  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism

Cite this

Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus. / Hassan, Krishnavathana; Heptulla, Rubina A.

In: Pediatric Diabetes, Vol. 10, No. 4, 2009, p. 264-268.

Research output: Contribution to journalArticle

@article{c78b2426072745529ab45c3f6d643688,
title = "Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus",
abstract = "Objective: The purpose of this study was to determine the effect of adjuvant premeal pramlintide with postmeal insulin on postprandial hyperglycemia in children with type 1 diabetes mellitus (T1DM). Methods: Eight adolescents with T1DM on intensive insulin therapy participated in an open-label, non-randomized, crossover study, comparing postprandial glucose excursions in study A (prescribed insulin regimen and given premeal) vs. study B (pramlintide + insulin). Prandial insulin dose for study B was decreased by 20{\%} and given postmeal, while pramlintide was given just before the meal. Blood glucose (BG), glucagon, and pramlintide concentrations were measured basally and at timed intervals during a 300-min study period. Results: Postprandial incremental BG for the duration of the study was reduced in study B vs. study A with AUC(-60to300min) (area under the curve) at 6600 ± 2371 vs. 20230 ± 3126 mg/dL/min (367 ± 132 vs. 1124 ± 174 mmol/L/min) (p < 0.001). Glucagon concentration was suppressed for ∼120 min following administration of 30 μg of pramlintide and postmeal insulin (p < 0.003). No severe hypoglycemic episodes were experienced in this study. Conclusions: Postprandial hyperglycemia is considerably reduced in adolescents with T1DM when treated with fixed-dose premeal pramlintide, and precisely calculated postmeal insulin, without significant side effects.",
keywords = "Children, Glucagon, Postprandial hyperglycemia, Pramlintide, T1DM",
author = "Krishnavathana Hassan and Heptulla, {Rubina A.}",
year = "2009",
doi = "10.1111/j.1399-5448.2008.00490.x",
language = "English (US)",
volume = "10",
pages = "264--268",
journal = "Pediatric Diabetes",
issn = "1399-543X",
publisher = "Blackwell Munksgaard",
number = "4",

}

TY - JOUR

T1 - Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus

AU - Hassan, Krishnavathana

AU - Heptulla, Rubina A.

PY - 2009

Y1 - 2009

N2 - Objective: The purpose of this study was to determine the effect of adjuvant premeal pramlintide with postmeal insulin on postprandial hyperglycemia in children with type 1 diabetes mellitus (T1DM). Methods: Eight adolescents with T1DM on intensive insulin therapy participated in an open-label, non-randomized, crossover study, comparing postprandial glucose excursions in study A (prescribed insulin regimen and given premeal) vs. study B (pramlintide + insulin). Prandial insulin dose for study B was decreased by 20% and given postmeal, while pramlintide was given just before the meal. Blood glucose (BG), glucagon, and pramlintide concentrations were measured basally and at timed intervals during a 300-min study period. Results: Postprandial incremental BG for the duration of the study was reduced in study B vs. study A with AUC(-60to300min) (area under the curve) at 6600 ± 2371 vs. 20230 ± 3126 mg/dL/min (367 ± 132 vs. 1124 ± 174 mmol/L/min) (p < 0.001). Glucagon concentration was suppressed for ∼120 min following administration of 30 μg of pramlintide and postmeal insulin (p < 0.003). No severe hypoglycemic episodes were experienced in this study. Conclusions: Postprandial hyperglycemia is considerably reduced in adolescents with T1DM when treated with fixed-dose premeal pramlintide, and precisely calculated postmeal insulin, without significant side effects.

AB - Objective: The purpose of this study was to determine the effect of adjuvant premeal pramlintide with postmeal insulin on postprandial hyperglycemia in children with type 1 diabetes mellitus (T1DM). Methods: Eight adolescents with T1DM on intensive insulin therapy participated in an open-label, non-randomized, crossover study, comparing postprandial glucose excursions in study A (prescribed insulin regimen and given premeal) vs. study B (pramlintide + insulin). Prandial insulin dose for study B was decreased by 20% and given postmeal, while pramlintide was given just before the meal. Blood glucose (BG), glucagon, and pramlintide concentrations were measured basally and at timed intervals during a 300-min study period. Results: Postprandial incremental BG for the duration of the study was reduced in study B vs. study A with AUC(-60to300min) (area under the curve) at 6600 ± 2371 vs. 20230 ± 3126 mg/dL/min (367 ± 132 vs. 1124 ± 174 mmol/L/min) (p < 0.001). Glucagon concentration was suppressed for ∼120 min following administration of 30 μg of pramlintide and postmeal insulin (p < 0.003). No severe hypoglycemic episodes were experienced in this study. Conclusions: Postprandial hyperglycemia is considerably reduced in adolescents with T1DM when treated with fixed-dose premeal pramlintide, and precisely calculated postmeal insulin, without significant side effects.

KW - Children

KW - Glucagon

KW - Postprandial hyperglycemia

KW - Pramlintide

KW - T1DM

UR - http://www.scopus.com/inward/record.url?scp=66649098434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66649098434&partnerID=8YFLogxK

U2 - 10.1111/j.1399-5448.2008.00490.x

DO - 10.1111/j.1399-5448.2008.00490.x

M3 - Article

VL - 10

SP - 264

EP - 268

JO - Pediatric Diabetes

JF - Pediatric Diabetes

SN - 1399-543X

IS - 4

ER -